A 3D printed Pfizer logo is placed near medicines from the same manufacturer in this illustration taken September 29, 2021. REUTERS/Dado Ruvic/Illustration
BERLIN, Nov 19 (Reuters) – Pfizer (PFE.N) plans to apply for a European authorisation of its experimental antiviral pill to treat COVID-19 on Friday, German weekly Wirtschaftswoche said, citing sources close to the European Medicines Agency (EMA) and the company.
The paper also said that acting German health minister Jens Spahn plans to buy Pfizer’s medicine. “The health ministry is in contact with Pfizer regarding a possible procurement of the antiviral drug Paxlovid,” Wirtschaftswoche quoted a ministry’s spokesperson as saying.
Pfizer has said that the pill cuts by 89% the chance of hospitalization or death for adults at risk of severe disease. read more
Register now for FREE unlimited access to reuters.com
Register
Reporting by Kirsti Knolle, editing by Thomas Escritt
Our Standards: The Thomson Reuters Trust Principles.
